BUSINESS COMBINATIONS (Details 8) (USD $)	12 Months Ended			1 Months Ended	12 Months Ended			3 Months Ended	12 Months Ended
	Dec. 31, 2012	Dec. 31, 2011	Dec. 31, 2012 Acquired IPR&D	Jan. 31, 2013 Elidel and Xerese	Dec. 31, 2012 Elidel and Xerese	Dec. 31, 2011 Elidel and Xerese	Jun. 29, 2011 Elidel and Xerese	Dec. 31, 2012 Elidel and Xerese Acquired IPR&D	Dec. 31, 2012 Elidel and Xerese Product brands
Business Combinations
Upfront payment							$ 76,000,000
Series of potential milestones to be paid							16,000,000
Amount of minimum royalty to be paid							120,000,000
Amount of additional minimum royalty to be paid							120,000,000
Fair value of upfront and contingent consideration							437,700,000
Acquisition-related contingent consideration	(5,266,000)	(10,986,000)			6,500,000	11,200,000
Payments of contingent consideration	103,926,000	31,800,000		14,500,000	88,000,000	28,500,000
Identifiable intangible assets, excluding acquired IPR&D					406,400,000
Acquired IPR&D	546,876,000	531,304,000			33,500,000
Deferred income taxes, net					(2,200,000)
Estimated weighted-average useful life									8 years
Risk-adjusted discount rate					13.00%
Impairment charges			$ 24,700,000					$ 24,700,000